Poster: AML-196: The First-in-Class Anti-CD47 Antibody Magrolimab in Combination with Azacitidine Is Well Tolerated and Effective in AML Patients: Phase 1b Results

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2021-09, Vol.21, p.S213-S213
Main Authors: Sallman, David, Asch, Adam, Kambhampati, Suman, Malki, Monzr Al, Zeidner, Joshua, Donnellan, William, Lee, Daniel, Vyas, Paresh, Jeyakumar, Deepa, Mannis, Gabriel, Tanaka, Tiffany, Chai-Ho, Wanxing, Larson, Richard, Whiteley, Andrew, Marcucci, Guido, Komrokji, Rami, Garcia-Manero, Guillermo, Van Elk, Joanna, Lin, Ming, Maute, Roy, Volkmer, Jens-Peter, Takimoto, Chris, Chao, Mark, Daver, Naval
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(21)01337-9